[
  {
    "title": "Regeneron Announces Investor Conference Presentations",
    "published": 1715025900,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 958.0,
      "2024-05-06T14:30:00+00:00": 953.3250122070312,
      "2024-05-06T15:30:00+00:00": 955.3200073242188,
      "2024-05-06T16:30:00+00:00": 953.1300048828125,
      "2024-05-06T17:30:00+00:00": 955.8900146484375,
      "2024-05-06T18:30:00+00:00": 956.260009765625,
      "2024-05-06T19:30:00+00:00": 955.739990234375
    },
    "sentiment": 0.9291732907295227
  },
  {
    "title": "Why Investors Are Eyeing Regeneron Pharmaceuticals Inc (REGN): The Key Drivers of Market ...",
    "published": 1714989720,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 958.0,
      "2024-05-06T14:30:00+00:00": 953.3250122070312,
      "2024-05-06T15:30:00+00:00": 955.3200073242188,
      "2024-05-06T16:30:00+00:00": 953.1300048828125,
      "2024-05-06T17:30:00+00:00": 955.8900146484375,
      "2024-05-06T18:30:00+00:00": 956.260009765625,
      "2024-05-06T19:30:00+00:00": 955.739990234375
    },
    "sentiment": 0.9107043743133545
  },
  {
    "title": "3 Biotech Stocks With the Potential to Make You an Overnight Millionaire",
    "published": 1714838400,
    "day_prices": {},
    "sentiment": 0.8275285959243774
  },
  {
    "title": "Amgen Could Become A Real Contender In The Obesity Market",
    "published": 1714813982,
    "day_prices": {},
    "sentiment": 0.5144065618515015
  },
  {
    "title": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript",
    "published": 1714745746,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.9181250929832458
  },
  {
    "title": "Assessing Regeneron Pharmaceuticals: Insights From 16 Financial Analysts",
    "published": 1714734000,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.8024248480796814
  },
  {
    "title": "Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...",
    "published": 1714720235,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.8544153571128845
  },
  {
    "title": "Truist Financial Keeps Their Buy Rating on Regeneron (REGN)",
    "published": 1714717860,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.8969982862472534
  },
  {
    "title": "Buy Rating Affirmed: Regeneron\u2019s Promising Pipeline and Potential for Surpassing Earnings Expectations",
    "published": 1714714620,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.9544216990470886
  },
  {
    "title": "Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales",
    "published": 1714658460,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9209335446357727
  },
  {
    "title": "Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...",
    "published": 1714653178,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.5983364582061768
  },
  {
    "title": "Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?",
    "published": 1714651222,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9447453022003174
  },
  {
    "title": "Regeneron Reports First Quarter 2024 Financial and Operating Results",
    "published": 1714645800,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.49029096961021423
  },
  {
    "title": "REGN Stock Earnings: Regeneron Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024",
    "published": 1714643700,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9565255045890808
  },
  {
    "title": "Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years",
    "published": 1714642560,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9336328506469727
  },
  {
    "title": "Regeneron says FDA requested additional analyses during Dupixent sBLA review",
    "published": 1714637220,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.8890453577041626
  },
  {
    "title": "Regeneron: Adjusted EPS down 4% in Q1",
    "published": 1714634606,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9743160605430603
  },
  {
    "title": "Regeneron falls after Q1 miss; announces $3B share buybacks",
    "published": 1714633020,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9192521572113037
  },
  {
    "title": "Regeneron misses profit estimates on weaker Eylea and Dupixent sales",
    "published": 1714631673,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.967100203037262
  },
  {
    "title": "Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook",
    "published": 1714628040,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.804728627204895
  },
  {
    "title": "Regeneron announces new $3B share repurchase program",
    "published": 1714627980,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.7082762122154236
  },
  {
    "title": "Regeneron's stock jumps 4% as analysts look to pipeline",
    "published": 1714618972,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9090224504470825
  },
  {
    "title": "Adverum Biotechnologies a new buy at H.C. Wainwright on wet AMD gene therapy",
    "published": 1714566060,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 889.0599975585938,
      "2024-05-01T14:30:00+00:00": 892.5032958984375,
      "2024-05-01T15:30:00+00:00": 899.385009765625,
      "2024-05-01T16:30:00+00:00": 899.6500244140625,
      "2024-05-01T17:30:00+00:00": 898.530029296875,
      "2024-05-01T18:30:00+00:00": 903.2000122070312,
      "2024-05-01T19:30:00+00:00": 912.14501953125
    },
    "sentiment": 0.5101462602615356
  },
  {
    "title": "Regeneron Pharmaceuticals Q1 2024 Earnings Preview",
    "published": 1714559820,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 889.0599975585938,
      "2024-05-01T14:30:00+00:00": 892.5032958984375,
      "2024-05-01T15:30:00+00:00": 899.385009765625,
      "2024-05-01T16:30:00+00:00": 899.6500244140625,
      "2024-05-01T17:30:00+00:00": 898.530029296875,
      "2024-05-01T18:30:00+00:00": 903.2000122070312,
      "2024-05-01T19:30:00+00:00": 912.14501953125
    },
    "sentiment": 0.8994348645210266
  },
  {
    "title": "Regeneron sees FY24 adjusted EPS $1.42-$1.49, consensus $1.46",
    "published": 1714545240,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 889.0599975585938,
      "2024-05-01T14:30:00+00:00": 892.5032958984375,
      "2024-05-01T15:30:00+00:00": 899.385009765625,
      "2024-05-01T16:30:00+00:00": 899.6500244140625,
      "2024-05-01T17:30:00+00:00": 898.530029296875,
      "2024-05-01T18:30:00+00:00": 903.2000122070312,
      "2024-05-01T19:30:00+00:00": 912.14501953125
    },
    "sentiment": 0.5758772492408752
  },
  {
    "title": "Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
    "published": 1715690529,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 980.0,
      "2024-05-14T14:30:00+00:00": 976.47998046875,
      "2024-05-14T15:30:00+00:00": 977.5499877929688,
      "2024-05-14T16:30:00+00:00": 978.625,
      "2024-05-14T17:30:00+00:00": 978.7050170898438,
      "2024-05-14T18:30:00+00:00": 984.0,
      "2024-05-14T19:30:00+00:00": 986.5499877929688
    },
    "sentiment": 0.9251840710639954
  },
  {
    "title": "Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years",
    "published": 1715679360,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 980.0,
      "2024-05-14T14:30:00+00:00": 976.47998046875,
      "2024-05-14T15:30:00+00:00": 977.5499877929688,
      "2024-05-14T16:30:00+00:00": 978.625,
      "2024-05-14T17:30:00+00:00": 978.7050170898438,
      "2024-05-14T18:30:00+00:00": 984.0,
      "2024-05-14T19:30:00+00:00": 986.5499877929688
    },
    "sentiment": 0.934251606464386
  },
  {
    "title": "Dupixent set for FDA review in adolescent chronic inflammatory sinus disease",
    "published": 1715612536,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.8244390487670898
  },
  {
    "title": "Regeneron gets FDA priority review for airway disease drug",
    "published": 1715580540,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.6390403509140015
  },
  {
    "title": "Regeneron, Sanofi announce FDA acceptance for priority review of Dupixent sBLA",
    "published": 1715574480,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.7778149247169495
  },
  {
    "title": "Regeneron initiated with bullish view at Evercore ISI, here's why",
    "published": 1715569860,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.7669188380241394
  },
  {
    "title": "Q1 2024 Intellia Therapeutics Inc Earnings Call",
    "published": 1715313196,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 970.0,
      "2024-05-10T14:30:00+00:00": 976.7000122070312,
      "2024-05-10T15:30:00+00:00": 972.4199829101562,
      "2024-05-10T16:30:00+00:00": 975.5900268554688,
      "2024-05-10T17:30:00+00:00": 975.7899780273438,
      "2024-05-10T18:30:00+00:00": 975.3099975585938,
      "2024-05-10T19:30:00+00:00": 976.0
    },
    "sentiment": 0.7336507439613342
  },
  {
    "title": "REGENERON PHARMACEUTICALS - LATEST DB-OTO RESULTS SHOW DRAMATICALLY IMPROVED HEARING TO NORMAL LEVELS IN A CHILD WITH PROFOUND GENETIC DEAFNESS WITHIN 24 WEEKS AND INITIAL HEARING IMPROVEMENTS IN A SECOND CHILD AT 6 WEEKS",
    "published": 1715248729,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 959.5900268554688,
      "2024-05-09T14:30:00+00:00": 964.1099853515625,
      "2024-05-09T15:30:00+00:00": 963.010009765625,
      "2024-05-09T16:30:00+00:00": 965.8599853515625,
      "2024-05-09T17:30:00+00:00": 968.9600219726562,
      "2024-05-09T18:30:00+00:00": 968.7000122070312,
      "2024-05-09T19:30:00+00:00": 968.47998046875
    },
    "sentiment": 0.9506378173828125
  },
  {
    "title": "Regeneron gene therapy improves hearing in two children",
    "published": 1715167800,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 969.9000244140625,
      "2024-05-08T14:30:00+00:00": 963.2999877929688,
      "2024-05-08T15:30:00+00:00": 959.10498046875,
      "2024-05-08T16:30:00+00:00": 958.52001953125,
      "2024-05-08T17:30:00+00:00": 956.280029296875,
      "2024-05-08T18:30:00+00:00": 954.0499877929688,
      "2024-05-08T19:30:00+00:00": 955.010009765625
    },
    "sentiment": 0.8213396668434143
  },
  {
    "title": "Regeneron gene therapy improves hearing in child deafness",
    "published": 1715152980,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 969.9000244140625,
      "2024-05-08T14:30:00+00:00": 963.2999877929688,
      "2024-05-08T15:30:00+00:00": 959.10498046875,
      "2024-05-08T16:30:00+00:00": 958.52001953125,
      "2024-05-08T17:30:00+00:00": 956.280029296875,
      "2024-05-08T18:30:00+00:00": 954.0499877929688,
      "2024-05-08T19:30:00+00:00": 955.010009765625
    },
    "sentiment": 0.7321152687072754
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Tilray (TLRY) and Regeneron (REGN)",
    "published": 1715131920,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 969.9000244140625,
      "2024-05-08T14:30:00+00:00": 963.2999877929688,
      "2024-05-08T15:30:00+00:00": 959.10498046875,
      "2024-05-08T16:30:00+00:00": 958.52001953125,
      "2024-05-08T17:30:00+00:00": 956.280029296875,
      "2024-05-08T18:30:00+00:00": 954.0499877929688,
      "2024-05-08T19:30:00+00:00": 955.010009765625
    },
    "sentiment": 0.9038944840431213
  },
  {
    "title": "Verona Pharma: Key Inflection Point Directly Ahead",
    "published": 1716470612,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 985.4299926757812,
      "2024-05-23T14:30:00+00:00": 987.7550048828125,
      "2024-05-23T15:30:00+00:00": 990.52001953125,
      "2024-05-23T16:30:00+00:00": 990.52001953125,
      "2024-05-23T17:30:00+00:00": 985.22998046875,
      "2024-05-23T18:30:00+00:00": 984.8900146484375,
      "2024-05-23T19:30:00+00:00": 981.469970703125
    },
    "sentiment": 0.914091944694519
  },
  {
    "title": "Regeneron reports 'positive' results from REGN7075 Phase 2 trial",
    "published": 1716437100,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 985.4299926757812,
      "2024-05-23T14:30:00+00:00": 987.7550048828125,
      "2024-05-23T15:30:00+00:00": 990.52001953125,
      "2024-05-23T16:30:00+00:00": 990.52001953125,
      "2024-05-23T17:30:00+00:00": 985.22998046875,
      "2024-05-23T18:30:00+00:00": 984.8900146484375,
      "2024-05-23T19:30:00+00:00": 981.469970703125
    },
    "sentiment": 0.9451427459716797
  },
  {
    "title": "Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?",
    "published": 1716386426,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 993.0,
      "2024-05-22T14:30:00+00:00": 994.7255859375,
      "2024-05-22T15:30:00+00:00": 989.52001953125,
      "2024-05-22T16:30:00+00:00": 990.375,
      "2024-05-22T17:30:00+00:00": 992.010009765625,
      "2024-05-22T18:30:00+00:00": 986.6500244140625,
      "2024-05-22T19:30:00+00:00": 986.010009765625
    },
    "sentiment": 0.9286871552467346
  },
  {
    "title": "Wells Fargo Remains a Buy on Regeneron (REGN)",
    "published": 1716351420,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 993.0,
      "2024-05-22T14:30:00+00:00": 994.7255859375,
      "2024-05-22T15:30:00+00:00": 989.52001953125,
      "2024-05-22T16:30:00+00:00": 990.375,
      "2024-05-22T17:30:00+00:00": 992.010009765625,
      "2024-05-22T18:30:00+00:00": 986.6500244140625,
      "2024-05-22T19:30:00+00:00": 986.010009765625
    },
    "sentiment": 0.9380198121070862
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Progyny (PGNY), Regeneron (REGN)",
    "published": 1716275520,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 987.989990234375,
      "2024-05-21T14:30:00+00:00": 995.1649780273438,
      "2024-05-21T15:30:00+00:00": 993.0,
      "2024-05-21T16:30:00+00:00": 992.125,
      "2024-05-21T17:30:00+00:00": 988.75,
      "2024-05-21T18:30:00+00:00": 993.0,
      "2024-05-21T19:30:00+00:00": 993.1799926757812
    },
    "sentiment": 0.6691092848777771
  },
  {
    "title": "7 Biotech Stocks That Could Breathe New Life Into Your Portfolio",
    "published": 1716226476,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 980.4199829101562,
      "2024-05-20T14:30:00+00:00": 982.6699829101562,
      "2024-05-20T15:30:00+00:00": 981.2899780273438,
      "2024-05-20T16:30:00+00:00": 980.64501953125,
      "2024-05-20T17:30:00+00:00": 982.9400024414062,
      "2024-05-20T18:30:00+00:00": 983.2100219726562,
      "2024-05-20T19:30:00+00:00": 985.1199951171875
    },
    "sentiment": 0.8768113255500793
  },
  {
    "title": "More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024",
    "published": 1716199949,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 980.4199829101562,
      "2024-05-20T14:30:00+00:00": 982.6699829101562,
      "2024-05-20T15:30:00+00:00": 981.2899780273438,
      "2024-05-20T16:30:00+00:00": 980.64501953125,
      "2024-05-20T17:30:00+00:00": 982.9400024414062,
      "2024-05-20T18:30:00+00:00": 983.2100219726562,
      "2024-05-20T19:30:00+00:00": 985.1199951171875
    },
    "sentiment": 0.9084648489952087
  },
  {
    "title": "(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest",
    "published": 1716171720,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 980.4199829101562,
      "2024-05-20T14:30:00+00:00": 982.6699829101562,
      "2024-05-20T15:30:00+00:00": 981.2899780273438,
      "2024-05-20T16:30:00+00:00": 980.64501953125,
      "2024-05-20T17:30:00+00:00": 982.9400024414062,
      "2024-05-20T18:30:00+00:00": 983.2100219726562,
      "2024-05-20T19:30:00+00:00": 985.1199951171875
    },
    "sentiment": 0.9037452936172485
  },
  {
    "title": "Roche Is Joining The Obesity Party But Questions Remain",
    "published": 1716031133,
    "day_prices": {},
    "sentiment": 0.9248262643814087
  },
  {
    "title": "Regeneron wins temporary restraining order preventing Eylea generic launch",
    "published": 1715936880,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 969.27001953125,
      "2024-05-17T14:30:00+00:00": 972.8300170898438,
      "2024-05-17T15:30:00+00:00": 976.0499877929688,
      "2024-05-17T16:30:00+00:00": 978.1199951171875,
      "2024-05-17T17:30:00+00:00": 978.8599853515625,
      "2024-05-17T18:30:00+00:00": 978.6599731445312,
      "2024-05-17T19:30:00+00:00": 979.7999877929688
    },
    "sentiment": 0.8732858300209045
  },
  {
    "title": "Regeneron wins temporary restraining order preventing Eylea generic launch (update)",
    "published": 1715908200,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 969.27001953125,
      "2024-05-17T14:30:00+00:00": 972.8300170898438,
      "2024-05-17T15:30:00+00:00": 976.0499877929688,
      "2024-05-17T16:30:00+00:00": 978.1199951171875,
      "2024-05-17T17:30:00+00:00": 978.8599853515625,
      "2024-05-17T18:30:00+00:00": 978.6599731445312,
      "2024-05-17T19:30:00+00:00": 979.7999877929688
    },
    "sentiment": 0.6379199624061584
  },
  {
    "title": "These 2 No-Brainer Growth Stocks Are Breaking New Ground",
    "published": 1715858100,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 976.9500122070312,
      "2024-05-16T14:30:00+00:00": 975.6300048828125,
      "2024-05-16T15:30:00+00:00": 977.155029296875,
      "2024-05-16T16:30:00+00:00": 974.75,
      "2024-05-16T17:30:00+00:00": 971.5349731445312,
      "2024-05-16T18:30:00+00:00": 969.6749877929688,
      "2024-05-16T19:30:00+00:00": 968.3250122070312
    },
    "sentiment": 0.7934203743934631
  },
  {
    "title": "FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD",
    "published": 1717162500,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 969.1400146484375,
      "2024-05-31T14:30:00+00:00": 977.77001953125,
      "2024-05-31T15:30:00+00:00": 973.97998046875,
      "2024-05-31T16:30:00+00:00": 971.7349853515625,
      "2024-05-31T17:30:00+00:00": 968.8400268554688,
      "2024-05-31T18:30:00+00:00": 971.625,
      "2024-05-31T19:30:00+00:00": 976.385009765625
    },
    "sentiment": 0.8736205101013184
  },
  {
    "title": "Regeneron/ Sanofi say FDA has delayed Dupixent COPD label",
    "published": 1717134600,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 969.1400146484375,
      "2024-05-31T14:30:00+00:00": 977.77001953125,
      "2024-05-31T15:30:00+00:00": 973.97998046875,
      "2024-05-31T16:30:00+00:00": 971.7349853515625,
      "2024-05-31T17:30:00+00:00": 968.8400268554688,
      "2024-05-31T18:30:00+00:00": 971.625,
      "2024-05-31T19:30:00+00:00": 976.385009765625
    },
    "sentiment": 0.5951675176620483
  },
  {
    "title": "Update on FDA Priority Review of Dupixent\u00ae (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation",
    "published": 1717131600,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 969.1400146484375,
      "2024-05-31T14:30:00+00:00": 977.77001953125,
      "2024-05-31T15:30:00+00:00": 973.97998046875,
      "2024-05-31T16:30:00+00:00": 971.7349853515625,
      "2024-05-31T17:30:00+00:00": 968.8400268554688,
      "2024-05-31T18:30:00+00:00": 971.625,
      "2024-05-31T19:30:00+00:00": 976.385009765625
    },
    "sentiment": 0.901075541973114
  },
  {
    "title": "Regeneron, Sanofi announce CHMP opinion recommending approval of Dupixent",
    "published": 1717129080,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 969.1400146484375,
      "2024-05-31T14:30:00+00:00": 977.77001953125,
      "2024-05-31T15:30:00+00:00": 973.97998046875,
      "2024-05-31T16:30:00+00:00": 971.7349853515625,
      "2024-05-31T17:30:00+00:00": 968.8400268554688,
      "2024-05-31T18:30:00+00:00": 971.625,
      "2024-05-31T19:30:00+00:00": 976.385009765625
    },
    "sentiment": 0.7743656039237976
  },
  {
    "title": "Buy Rating Affirmed for Regeneron Despite FDA Delay on Dupixent for COPD",
    "published": 1717120080,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 969.1400146484375,
      "2024-05-31T14:30:00+00:00": 977.77001953125,
      "2024-05-31T15:30:00+00:00": 973.97998046875,
      "2024-05-31T16:30:00+00:00": 971.7349853515625,
      "2024-05-31T17:30:00+00:00": 968.8400268554688,
      "2024-05-31T18:30:00+00:00": 971.625,
      "2024-05-31T19:30:00+00:00": 976.385009765625
    },
    "sentiment": 0.8967174291610718
  },
  {
    "title": "Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution",
    "published": 1716811218,
    "day_prices": {},
    "sentiment": 0.8144292235374451
  },
  {
    "title": "Eli Lilly: Addressing Supply Challenges Should Accelerate Growth",
    "published": 1716736779,
    "day_prices": {},
    "sentiment": 0.9003474116325378
  },
  {
    "title": "2 Biotech Stocks to Buy in May",
    "published": 1716645600,
    "day_prices": {},
    "sentiment": 0.8453677892684937
  },
  {
    "title": "Regeneron (REGN) Announces Positive Data on Oncology Candidate",
    "published": 1716557280,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 984.0399780273438,
      "2024-05-24T14:30:00+00:00": 985.1799926757812,
      "2024-05-24T15:30:00+00:00": 988.6500244140625,
      "2024-05-24T16:30:00+00:00": 992.9400024414062,
      "2024-05-24T17:30:00+00:00": 989.0900268554688,
      "2024-05-24T18:30:00+00:00": 989.1900024414062,
      "2024-05-24T19:30:00+00:00": 986.3200073242188
    },
    "sentiment": 0.9389208555221558
  },
  {
    "title": "After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February",
    "published": 1716548700,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 984.0399780273438,
      "2024-05-24T14:30:00+00:00": 985.1799926757812,
      "2024-05-24T15:30:00+00:00": 988.6500244140625,
      "2024-05-24T16:30:00+00:00": 992.9400024414062,
      "2024-05-24T17:30:00+00:00": 989.0900268554688,
      "2024-05-24T18:30:00+00:00": 989.1900024414062,
      "2024-05-24T19:30:00+00:00": 986.3200073242188
    },
    "sentiment": 0.9297510385513306
  },
  {
    "title": "What's Going On With Regeneron Pharmaceuticals Stock On Friday?",
    "published": 1719581226,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 1054.81005859375,
      "2024-06-28T14:30:00+00:00": 1048.969970703125,
      "2024-06-28T15:30:00+00:00": 1047.4599609375,
      "2024-06-28T16:30:00+00:00": 1047.27001953125,
      "2024-06-28T17:30:00+00:00": 1045.0,
      "2024-06-28T18:30:00+00:00": 1054.9599609375,
      "2024-06-28T19:30:00+00:00": 1052.1600341796875
    },
    "sentiment": 0.5751727223396301
  },
  {
    "title": "Regeneron lymphoma antibody drug endorsed for conditional approval in EU",
    "published": 1719561780,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 1054.81005859375,
      "2024-06-28T14:30:00+00:00": 1048.969970703125,
      "2024-06-28T15:30:00+00:00": 1047.4599609375,
      "2024-06-28T16:30:00+00:00": 1047.27001953125,
      "2024-06-28T17:30:00+00:00": 1045.0,
      "2024-06-28T18:30:00+00:00": 1054.9599609375,
      "2024-06-28T19:30:00+00:00": 1052.1600341796875
    },
    "sentiment": 0.7276400923728943
  },
  {
    "title": "CHMP recommends Regeneron lymphoma antibody drug for conditional approval",
    "published": 1719560640,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 1054.81005859375,
      "2024-06-28T14:30:00+00:00": 1048.969970703125,
      "2024-06-28T15:30:00+00:00": 1047.4599609375,
      "2024-06-28T16:30:00+00:00": 1047.27001953125,
      "2024-06-28T17:30:00+00:00": 1045.0,
      "2024-06-28T18:30:00+00:00": 1054.9599609375,
      "2024-06-28T19:30:00+00:00": 1052.1600341796875
    },
    "sentiment": 0.7571228742599487
  },
  {
    "title": "Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024",
    "published": 1719518700,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 1071.219970703125,
      "2024-06-27T14:30:00+00:00": 1057.030029296875,
      "2024-06-27T15:30:00+00:00": 1056.35498046875,
      "2024-06-27T16:30:00+00:00": 1054.6700439453125,
      "2024-06-27T17:30:00+00:00": 1054.8800048828125,
      "2024-06-27T18:30:00+00:00": 1049.27001953125,
      "2024-06-27T19:30:00+00:00": 1047.6500244140625
    },
    "sentiment": 0.9491375684738159
  },
  {
    "title": "REGN August 9th Options Begin Trading",
    "published": 1719485460,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 1071.219970703125,
      "2024-06-27T14:30:00+00:00": 1057.030029296875,
      "2024-06-27T15:30:00+00:00": 1056.35498046875,
      "2024-06-27T16:30:00+00:00": 1054.6700439453125,
      "2024-06-27T17:30:00+00:00": 1054.8800048828125,
      "2024-06-27T18:30:00+00:00": 1049.27001953125,
      "2024-06-27T19:30:00+00:00": 1047.6500244140625
    },
    "sentiment": 0.9396058320999146
  },
  {
    "title": "Sanofi - Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM",
    "published": 1719477111,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 1071.219970703125,
      "2024-06-27T14:30:00+00:00": 1057.030029296875,
      "2024-06-27T15:30:00+00:00": 1056.35498046875,
      "2024-06-27T16:30:00+00:00": 1054.6700439453125,
      "2024-06-27T17:30:00+00:00": 1054.8800048828125,
      "2024-06-27T18:30:00+00:00": 1049.27001953125,
      "2024-06-27T19:30:00+00:00": 1047.6500244140625
    },
    "sentiment": 0.7777183055877686
  },
  {
    "title": "Evercore ISI Sticks to Its Buy Rating for Regeneron (REGN)",
    "published": 1719457020,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 1071.219970703125,
      "2024-06-27T14:30:00+00:00": 1057.030029296875,
      "2024-06-27T15:30:00+00:00": 1056.35498046875,
      "2024-06-27T16:30:00+00:00": 1054.6700439453125,
      "2024-06-27T17:30:00+00:00": 1054.8800048828125,
      "2024-06-27T18:30:00+00:00": 1049.27001953125,
      "2024-06-27T19:30:00+00:00": 1047.6500244140625
    },
    "sentiment": 0.7291892170906067
  },
  {
    "title": "FDA approves Verona Pharma's therapy for 'smoker's lungs'",
    "published": 1719421224,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 1067.0,
      "2024-06-26T14:30:00+00:00": 1056.4000244140625,
      "2024-06-26T15:30:00+00:00": 1064.6300048828125,
      "2024-06-26T16:30:00+00:00": 1073.510009765625,
      "2024-06-26T17:30:00+00:00": 1067.3800048828125,
      "2024-06-26T18:30:00+00:00": 1065.43994140625,
      "2024-06-26T19:30:00+00:00": 1067.0050048828125
    },
    "sentiment": 0.7555431127548218
  },
  {
    "title": "Buy Rating on Regeneron: Promising Obesity Treatment Prospects Amid Phase 2 Trials",
    "published": 1719369420,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 1067.0,
      "2024-06-26T14:30:00+00:00": 1056.4000244140625,
      "2024-06-26T15:30:00+00:00": 1064.6300048828125,
      "2024-06-26T16:30:00+00:00": 1073.510009765625,
      "2024-06-26T17:30:00+00:00": 1067.3800048828125,
      "2024-06-26T18:30:00+00:00": 1065.43994140625,
      "2024-06-26T19:30:00+00:00": 1067.0050048828125
    },
    "sentiment": 0.9509590864181519
  },
  {
    "title": "Regeneron price target raised by $110 at Argus, here's why",
    "published": 1719299520,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 1068.1199951171875,
      "2024-06-25T14:30:00+00:00": 1078.469970703125,
      "2024-06-25T15:30:00+00:00": 1075.2099609375,
      "2024-06-25T16:30:00+00:00": 1077.260009765625,
      "2024-06-25T17:30:00+00:00": 1072.52001953125,
      "2024-06-25T18:30:00+00:00": 1073.31005859375,
      "2024-06-25T19:30:00+00:00": 1071.9749755859375
    },
    "sentiment": 0.740278422832489
  },
  {
    "title": "Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity",
    "published": 1719281160,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 1068.1199951171875,
      "2024-06-25T14:30:00+00:00": 1078.469970703125,
      "2024-06-25T15:30:00+00:00": 1075.2099609375,
      "2024-06-25T16:30:00+00:00": 1077.260009765625,
      "2024-06-25T17:30:00+00:00": 1072.52001953125,
      "2024-06-25T18:30:00+00:00": 1073.31005859375,
      "2024-06-25T19:30:00+00:00": 1071.9749755859375
    },
    "sentiment": 0.8665580749511719
  },
  {
    "title": "The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 13 Experts",
    "published": 1719227220,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 1060.0,
      "2024-06-24T14:30:00+00:00": 1062.8399658203125,
      "2024-06-24T15:30:00+00:00": 1062.530029296875,
      "2024-06-24T16:30:00+00:00": 1067.1800537109375,
      "2024-06-24T17:30:00+00:00": 1062.9150390625,
      "2024-06-24T18:30:00+00:00": 1064.7550048828125,
      "2024-06-24T19:30:00+00:00": 1063.949951171875
    },
    "sentiment": 0.8978100419044495
  },
  {
    "title": "RBC Capital Sticks to Their Buy Rating for Regeneron (REGN)",
    "published": 1719207360,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 1060.0,
      "2024-06-24T14:30:00+00:00": 1062.8399658203125,
      "2024-06-24T15:30:00+00:00": 1062.530029296875,
      "2024-06-24T16:30:00+00:00": 1067.1800537109375,
      "2024-06-24T17:30:00+00:00": 1062.9150390625,
      "2024-06-24T18:30:00+00:00": 1064.7550048828125,
      "2024-06-24T19:30:00+00:00": 1063.949951171875
    },
    "sentiment": 0.6472666263580322
  },
  {
    "title": "Regeneron Pharmaceuticals' Approach To Improve Quality Of Weight Loss Has Merit: Goldman Sachs",
    "published": 1719193140,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 1060.0,
      "2024-06-24T14:30:00+00:00": 1062.8399658203125,
      "2024-06-24T15:30:00+00:00": 1062.530029296875,
      "2024-06-24T16:30:00+00:00": 1067.1800537109375,
      "2024-06-24T17:30:00+00:00": 1062.9150390625,
      "2024-06-24T18:30:00+00:00": 1064.7550048828125,
      "2024-06-24T19:30:00+00:00": 1063.949951171875
    },
    "sentiment": 0.5572167634963989
  },
  {
    "title": "Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024",
    "published": 1718965800,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 1047.7099609375,
      "2024-06-21T14:30:00+00:00": 1051.300048828125,
      "2024-06-21T15:30:00+00:00": 1045.6099853515625,
      "2024-06-21T16:30:00+00:00": 1052.9000244140625,
      "2024-06-21T17:30:00+00:00": 1051.9100341796875,
      "2024-06-21T18:30:00+00:00": 1052.489990234375,
      "2024-06-21T19:30:00+00:00": 1055.7550048828125
    },
    "sentiment": 0.5604956150054932
  },
  {
    "title": "Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?",
    "published": 1718917457,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 1038.43994140625,
      "2024-06-20T14:30:00+00:00": 1030.239990234375,
      "2024-06-20T15:30:00+00:00": 1033.2900390625,
      "2024-06-20T16:30:00+00:00": 1038.18505859375,
      "2024-06-20T17:30:00+00:00": 1041.4200439453125,
      "2024-06-20T18:30:00+00:00": 1042.25,
      "2024-06-20T19:30:00+00:00": 1043.31005859375
    },
    "sentiment": 0.7612041234970093
  },
  {
    "title": "Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?",
    "published": 1718731320,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 1046.5,
      "2024-06-18T14:30:00+00:00": 1051.3050537109375,
      "2024-06-18T15:30:00+00:00": 1048.2099609375,
      "2024-06-18T16:30:00+00:00": 1045.969970703125,
      "2024-06-18T17:30:00+00:00": 1046.6400146484375,
      "2024-06-18T18:30:00+00:00": 1042.3900146484375,
      "2024-06-18T19:30:00+00:00": 1036.8599853515625
    },
    "sentiment": 0.770570695400238
  },
  {
    "title": "Regeneron Pharmaceuticals Reaches Analyst Target Price",
    "published": 1718690400,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 1046.5,
      "2024-06-18T14:30:00+00:00": 1051.3050537109375,
      "2024-06-18T15:30:00+00:00": 1048.2099609375,
      "2024-06-18T16:30:00+00:00": 1045.969970703125,
      "2024-06-18T17:30:00+00:00": 1046.6400146484375,
      "2024-06-18T18:30:00+00:00": 1042.3900146484375,
      "2024-06-18T19:30:00+00:00": 1036.8599853515625
    },
    "sentiment": 0.8991509675979614
  },
  {
    "title": "EHA2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma",
    "published": 1718637819,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 1036.52001953125,
      "2024-06-17T14:30:00+00:00": 1040.4200439453125,
      "2024-06-17T15:30:00+00:00": 1043.699951171875,
      "2024-06-17T16:30:00+00:00": 1043.4749755859375,
      "2024-06-17T17:30:00+00:00": 1045.989990234375,
      "2024-06-17T18:30:00+00:00": 1046.5899658203125,
      "2024-06-17T19:30:00+00:00": 1046.6700439453125
    },
    "sentiment": 0.9492384195327759
  },
  {
    "title": "Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma",
    "published": 1718532600,
    "day_prices": {},
    "sentiment": 0.9204365015029907
  },
  {
    "title": "Regeneron presents follow-up data from pivotal Phase 1/2 LINKER-MM1 trial",
    "published": 1718518920,
    "day_prices": {},
    "sentiment": 0.9348471760749817
  },
  {
    "title": "Ocular Therapeutix jumps after investor day updates",
    "published": 1718366580,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 1018.0800170898438,
      "2024-06-14T14:30:00+00:00": 1031.56005859375,
      "2024-06-14T15:30:00+00:00": 1035.5899658203125,
      "2024-06-14T16:30:00+00:00": 1040.969970703125,
      "2024-06-14T17:30:00+00:00": 1036.93994140625,
      "2024-06-14T18:30:00+00:00": 1033.3900146484375,
      "2024-06-14T19:30:00+00:00": 1034.97998046875
    },
    "sentiment": 0.36898696422576904
  },
  {
    "title": "Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past five years",
    "published": 1718362817,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 1018.0800170898438,
      "2024-06-14T14:30:00+00:00": 1031.56005859375,
      "2024-06-14T15:30:00+00:00": 1035.5899658203125,
      "2024-06-14T16:30:00+00:00": 1040.969970703125,
      "2024-06-14T17:30:00+00:00": 1036.93994140625,
      "2024-06-14T18:30:00+00:00": 1033.3900146484375,
      "2024-06-14T19:30:00+00:00": 1034.97998046875
    },
    "sentiment": 0.9410742521286011
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Regeneron (REGN) and Ocular Therapeutix (OCUL)",
    "published": 1718347860,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 1018.0800170898438,
      "2024-06-14T14:30:00+00:00": 1031.56005859375,
      "2024-06-14T15:30:00+00:00": 1035.5899658203125,
      "2024-06-14T16:30:00+00:00": 1040.969970703125,
      "2024-06-14T17:30:00+00:00": 1036.93994140625,
      "2024-06-14T18:30:00+00:00": 1033.3900146484375,
      "2024-06-14T19:30:00+00:00": 1034.97998046875
    },
    "sentiment": 0.8974414467811584
  },
  {
    "title": "Regeneron's Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market",
    "published": 1718268060,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 1022.6799926757812,
      "2024-06-13T14:30:00+00:00": 1020.739990234375,
      "2024-06-13T15:30:00+00:00": 1029.97998046875,
      "2024-06-13T16:30:00+00:00": 1021.8200073242188,
      "2024-06-13T17:30:00+00:00": 1019.9099731445312,
      "2024-06-13T18:30:00+00:00": 1020.9099731445312,
      "2024-06-13T19:30:00+00:00": 1027.7099609375
    },
    "sentiment": 0.8510369062423706
  },
  {
    "title": "Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club",
    "published": 1718222597,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 1014.8099975585938,
      "2024-06-12T14:30:00+00:00": 1013.7750244140625,
      "2024-06-12T15:30:00+00:00": 1017.297607421875,
      "2024-06-12T16:30:00+00:00": 1018.47998046875,
      "2024-06-12T17:30:00+00:00": 1022.969970703125,
      "2024-06-12T18:30:00+00:00": 1022.7849731445312,
      "2024-06-12T19:30:00+00:00": 1027.3050537109375
    },
    "sentiment": 0.9302054047584534
  },
  {
    "title": "Regeneron\u2019s Strategic Litigation and Market Exclusivity Uphold Buy Rating",
    "published": 1718174220,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 1014.8099975585938,
      "2024-06-12T14:30:00+00:00": 1013.7750244140625,
      "2024-06-12T15:30:00+00:00": 1017.297607421875,
      "2024-06-12T16:30:00+00:00": 1018.47998046875,
      "2024-06-12T17:30:00+00:00": 1022.969970703125,
      "2024-06-12T18:30:00+00:00": 1022.7849731445312,
      "2024-06-12T19:30:00+00:00": 1027.3050537109375
    },
    "sentiment": 0.5442875623703003
  },
  {
    "title": "Regeneron price target raised by $75 at Wells Fargo, here's why",
    "published": 1718169720,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 1014.8099975585938,
      "2024-06-12T14:30:00+00:00": 1013.7750244140625,
      "2024-06-12T15:30:00+00:00": 1017.297607421875,
      "2024-06-12T16:30:00+00:00": 1018.47998046875,
      "2024-06-12T17:30:00+00:00": 1022.969970703125,
      "2024-06-12T18:30:00+00:00": 1022.7849731445312,
      "2024-06-12T19:30:00+00:00": 1027.3050537109375
    },
    "sentiment": 0.6120163798332214
  },
  {
    "title": "Regeneron and Sanofi get FDA approval for juvenile arthritis treatment",
    "published": 1718115420,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 998.0800170898438,
      "2024-06-11T14:30:00+00:00": 1004.2000122070312,
      "2024-06-11T15:30:00+00:00": 1001.5850219726562,
      "2024-06-11T16:30:00+00:00": 1001.2100219726562,
      "2024-06-11T17:30:00+00:00": 1005.2949829101562,
      "2024-06-11T18:30:00+00:00": 1012.8775024414062,
      "2024-06-11T19:30:00+00:00": 1008.2650146484375
    },
    "sentiment": 0.6627925038337708
  },
  {
    "title": "Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)",
    "published": 1718100425,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 998.0800170898438,
      "2024-06-11T14:30:00+00:00": 1004.2000122070312,
      "2024-06-11T15:30:00+00:00": 1001.5850219726562,
      "2024-06-11T16:30:00+00:00": 1001.2100219726562,
      "2024-06-11T17:30:00+00:00": 1005.2949829101562,
      "2024-06-11T18:30:00+00:00": 1012.8775024414062,
      "2024-06-11T19:30:00+00:00": 1008.2650146484375
    },
    "sentiment": 0.9237704277038574
  },
  {
    "title": "Peering Into Regeneron Pharmaceuticals's Recent Short Interest",
    "published": 1718077680,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 998.0800170898438,
      "2024-06-11T14:30:00+00:00": 1004.2000122070312,
      "2024-06-11T15:30:00+00:00": 1001.5850219726562,
      "2024-06-11T16:30:00+00:00": 1001.2100219726562,
      "2024-06-11T17:30:00+00:00": 1005.2949829101562,
      "2024-06-11T18:30:00+00:00": 1012.8775024414062,
      "2024-06-11T19:30:00+00:00": 1008.2650146484375
    },
    "sentiment": 0.9293442964553833
  },
  {
    "title": "Regeneron wins injunction blocking Mylan from launching generic version of its eye drug Eylea",
    "published": 1718071140,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 998.0800170898438,
      "2024-06-11T14:30:00+00:00": 1004.2000122070312,
      "2024-06-11T15:30:00+00:00": 1001.5850219726562,
      "2024-06-11T16:30:00+00:00": 1001.2100219726562,
      "2024-06-11T17:30:00+00:00": 1005.2949829101562,
      "2024-06-11T18:30:00+00:00": 1012.8775024414062,
      "2024-06-11T19:30:00+00:00": 1008.2650146484375
    },
    "sentiment": 0.8909749984741211
  },
  {
    "title": "Regeneron wins permanent injunction blocking generic version of its eye drug Eylea",
    "published": 1718070480,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 998.0800170898438,
      "2024-06-11T14:30:00+00:00": 1004.2000122070312,
      "2024-06-11T15:30:00+00:00": 1001.5850219726562,
      "2024-06-11T16:30:00+00:00": 1001.2100219726562,
      "2024-06-11T17:30:00+00:00": 1005.2949829101562,
      "2024-06-11T18:30:00+00:00": 1012.8775024414062,
      "2024-06-11T19:30:00+00:00": 1008.2650146484375
    },
    "sentiment": 0.9468855857849121
  },
  {
    "title": "Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its Financial Health?",
    "published": 1717844416,
    "day_prices": {},
    "sentiment": 0.8941787481307983
  },
  {
    "title": "Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside",
    "published": 1717724040,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 999.0,
      "2024-06-07T14:30:00+00:00": 999.5449829101562,
      "2024-06-07T15:30:00+00:00": 1002.1099853515625,
      "2024-06-07T16:30:00+00:00": 1002.280029296875,
      "2024-06-07T17:30:00+00:00": 1004.9749755859375,
      "2024-06-07T18:30:00+00:00": 1006.0399780273438,
      "2024-06-07T19:30:00+00:00": 1003.6400146484375
    },
    "sentiment": 0.8103159070014954
  },
  {
    "title": "Regeneron Pharmaceuticals Now #88 Largest Company, Surpassing Chubb",
    "published": 1717558920,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 993.4400024414062,
      "2024-06-05T14:30:00+00:00": 997.0,
      "2024-06-05T15:30:00+00:00": 1008.0,
      "2024-06-05T16:30:00+00:00": 1013.030029296875,
      "2024-06-05T17:30:00+00:00": 1013.3900146484375,
      "2024-06-05T18:30:00+00:00": 1010.9650268554688,
      "2024-06-05T19:30:00+00:00": 1009.8049926757812
    },
    "sentiment": 0.6883761286735535
  },
  {
    "title": "Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals",
    "published": 1717491960,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 989.7899780273438,
      "2024-06-04T14:30:00+00:00": 998.159912109375,
      "2024-06-04T15:30:00+00:00": 992.7000122070312,
      "2024-06-04T16:30:00+00:00": 991.64501953125,
      "2024-06-04T17:30:00+00:00": 996.6900024414062,
      "2024-06-04T18:30:00+00:00": 999.0,
      "2024-06-04T19:30:00+00:00": 992.989990234375
    },
    "sentiment": 0.727397084236145
  },
  {
    "title": "Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) the Best Bet in Gene Therapy Industry?",
    "published": 1717446140,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 980.1599731445312,
      "2024-06-03T14:30:00+00:00": 999.0899047851562,
      "2024-06-03T15:30:00+00:00": 999.3400268554688,
      "2024-06-03T16:30:00+00:00": 992.2418212890625,
      "2024-06-03T17:30:00+00:00": 988.9199829101562,
      "2024-06-03T18:30:00+00:00": 994.7349853515625,
      "2024-06-03T19:30:00+00:00": 993.3499755859375
    },
    "sentiment": 0.8735712766647339
  },
  {
    "title": "Buy Rating Affirmed for REGN on Dupixent\u2019s Strong Prospects Despite PDUFA Delay",
    "published": 1717396020,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 980.1599731445312,
      "2024-06-03T14:30:00+00:00": 999.0899047851562,
      "2024-06-03T15:30:00+00:00": 999.3400268554688,
      "2024-06-03T16:30:00+00:00": 992.2418212890625,
      "2024-06-03T17:30:00+00:00": 988.9199829101562,
      "2024-06-03T18:30:00+00:00": 994.7349853515625,
      "2024-06-03T19:30:00+00:00": 993.3499755859375
    },
    "sentiment": 0.954129159450531
  },
  {
    "title": "FibroGen, Regeneron in deal for oncology assets in evaluation combo study",
    "published": 1717384680,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 980.1599731445312,
      "2024-06-03T14:30:00+00:00": 999.0899047851562,
      "2024-06-03T15:30:00+00:00": 999.3400268554688,
      "2024-06-03T16:30:00+00:00": 992.2418212890625,
      "2024-06-03T17:30:00+00:00": 988.9199829101562,
      "2024-06-03T18:30:00+00:00": 994.7349853515625,
      "2024-06-03T19:30:00+00:00": 993.3499755859375
    },
    "sentiment": 0.747059166431427
  },
  {
    "title": "What To Expect From Regeneron Pharmaceuticals Inc (REGN) Q2 2024 Earnings",
    "published": 1722422580,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 1082.199951171875,
      "2024-07-31T14:30:00+00:00": 1079.0999755859375,
      "2024-07-31T15:30:00+00:00": 1087.989990234375,
      "2024-07-31T16:30:00+00:00": 1087.6500244140625,
      "2024-07-31T17:30:00+00:00": 1083.5,
      "2024-07-31T18:30:00+00:00": 1087.97998046875,
      "2024-07-31T19:30:00+00:00": 1081.47998046875
    },
    "sentiment": 0.9437735080718994
  },
  {
    "title": "Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth",
    "published": 1722348079,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 1082.6400146484375,
      "2024-07-30T14:30:00+00:00": 1082.68505859375,
      "2024-07-30T15:30:00+00:00": 1076.35498046875,
      "2024-07-30T16:30:00+00:00": 1075.4749755859375,
      "2024-07-30T17:30:00+00:00": 1069.530029296875,
      "2024-07-30T18:30:00+00:00": 1072.969970703125,
      "2024-07-30T19:30:00+00:00": 1073.8199462890625
    },
    "sentiment": 0.9193093776702881
  },
  {
    "title": "Roche's Vabysmo gains indication in Europe for retinal vein occlusion",
    "published": 1722332640,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 1082.6400146484375,
      "2024-07-30T14:30:00+00:00": 1082.68505859375,
      "2024-07-30T15:30:00+00:00": 1076.35498046875,
      "2024-07-30T16:30:00+00:00": 1075.4749755859375,
      "2024-07-30T17:30:00+00:00": 1069.530029296875,
      "2024-07-30T18:30:00+00:00": 1072.969970703125,
      "2024-07-30T19:30:00+00:00": 1073.8199462890625
    },
    "sentiment": 0.74959397315979
  },
  {
    "title": "BioNTech posts mid-stage win for mRNA cancer drug with Regeneron\u2019s Libtayo",
    "published": 1722325140,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 1082.6400146484375,
      "2024-07-30T14:30:00+00:00": 1082.68505859375,
      "2024-07-30T15:30:00+00:00": 1076.35498046875,
      "2024-07-30T16:30:00+00:00": 1075.4749755859375,
      "2024-07-30T17:30:00+00:00": 1069.530029296875,
      "2024-07-30T18:30:00+00:00": 1072.969970703125,
      "2024-07-30T19:30:00+00:00": 1073.8199462890625
    },
    "sentiment": 0.9179615378379822
  },
  {
    "title": "Countdown to Regeneron (REGN) Q2 Earnings: Wall Street Forecasts for Key Metrics",
    "published": 1722258970,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 1073.6199951171875,
      "2024-07-29T14:30:00+00:00": 1077.925048828125,
      "2024-07-29T15:30:00+00:00": 1076.800048828125,
      "2024-07-29T16:30:00+00:00": 1077.8499755859375,
      "2024-07-29T17:30:00+00:00": 1076.8800048828125,
      "2024-07-29T18:30:00+00:00": 1074.3299560546875,
      "2024-07-29T19:30:00+00:00": 1075.6650390625
    },
    "sentiment": 0.8959308862686157
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN) and Roche Holding AG (OtherRHHVF)",
    "published": 1721959020,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 1067.5400390625,
      "2024-07-26T14:30:00+00:00": 1086.489990234375,
      "2024-07-26T15:30:00+00:00": 1090.219970703125,
      "2024-07-26T16:30:00+00:00": 1080.9849853515625,
      "2024-07-26T17:30:00+00:00": 1083.6500244140625,
      "2024-07-26T18:30:00+00:00": 1080.5400390625,
      "2024-07-26T19:30:00+00:00": 1080.0
    },
    "sentiment": 0.789087176322937
  },
  {
    "title": "Regeneron (REGN) Earnings Expected to Grow: Should You Buy?",
    "published": 1721916129,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 1070.75,
      "2024-07-25T14:30:00+00:00": 1097.050048828125,
      "2024-07-25T15:30:00+00:00": 1088.0374755859375,
      "2024-07-25T16:30:00+00:00": 1084.18994140625,
      "2024-07-25T17:30:00+00:00": 1079.8499755859375,
      "2024-07-25T18:30:00+00:00": 1070.8599853515625,
      "2024-07-25T19:30:00+00:00": 1067.9300537109375
    },
    "sentiment": 0.8080033659934998
  },
  {
    "title": "Regeneron (REGN) to Report Q2 Earnings: What's in the Cards?",
    "published": 1721824620,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 1056.0,
      "2024-07-24T14:30:00+00:00": 1056.260009765625,
      "2024-07-24T15:30:00+00:00": 1056.550048828125,
      "2024-07-24T16:30:00+00:00": 1065.719970703125,
      "2024-07-24T17:30:00+00:00": 1061.260009765625,
      "2024-07-24T18:30:00+00:00": 1060.2249755859375,
      "2024-07-24T19:30:00+00:00": 1059.02001953125
    },
    "sentiment": 0.9267368912696838
  },
  {
    "title": "Ocular Therapeutix: A Speculative Investment For Risk-Tolerant Investors",
    "published": 1721735266,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 1066.81005859375,
      "2024-07-23T14:30:00+00:00": 1070.7550048828125,
      "2024-07-23T15:30:00+00:00": 1072.300048828125,
      "2024-07-23T16:30:00+00:00": 1066.0400390625,
      "2024-07-23T17:30:00+00:00": 1064.1300048828125,
      "2024-07-23T18:30:00+00:00": 1063.3699951171875,
      "2024-07-23T19:30:00+00:00": 1058.0550537109375
    },
    "sentiment": 0.8755255341529846
  },
  {
    "title": "TD Cowen Keeps Their Buy Rating on Regeneron (REGN)",
    "published": 1721716560,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 1066.81005859375,
      "2024-07-23T14:30:00+00:00": 1070.7550048828125,
      "2024-07-23T15:30:00+00:00": 1072.300048828125,
      "2024-07-23T16:30:00+00:00": 1066.0400390625,
      "2024-07-23T17:30:00+00:00": 1064.1300048828125,
      "2024-07-23T18:30:00+00:00": 1063.3699951171875,
      "2024-07-23T19:30:00+00:00": 1058.0550537109375
    },
    "sentiment": 0.9167156219482422
  },
  {
    "title": "$100 Invested In This Stock 15 Years Ago Would Be Worth $5,100 Today",
    "published": 1721613780,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 1075.3499755859375,
      "2024-07-22T14:30:00+00:00": 1068.3399658203125,
      "2024-07-22T15:30:00+00:00": 1066.81494140625,
      "2024-07-22T16:30:00+00:00": 1067.0400390625,
      "2024-07-22T17:30:00+00:00": 1072.81005859375,
      "2024-07-22T18:30:00+00:00": 1073.31005859375,
      "2024-07-22T19:30:00+00:00": 1071.300048828125
    },
    "sentiment": 0.9484459757804871
  },
  {
    "title": "Piper Sandler Remains a Buy on Regeneron (REGN)",
    "published": 1721368020,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 1072.18994140625,
      "2024-07-19T14:30:00+00:00": 1065.7149658203125,
      "2024-07-19T15:30:00+00:00": 1064.969970703125,
      "2024-07-19T16:30:00+00:00": 1071.14501953125,
      "2024-07-19T17:30:00+00:00": 1064.97998046875,
      "2024-07-19T18:30:00+00:00": 1064.9000244140625,
      "2024-07-19T19:30:00+00:00": 1066.10498046875
    },
    "sentiment": 0.9470075368881226
  },
  {
    "title": "Causation Split: First Circuit Pauses Teva Appeal; Regeneron Appeal Going Forward",
    "published": 1721096169,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 1087.8900146484375,
      "2024-07-16T14:30:00+00:00": 1092.3399658203125,
      "2024-07-16T15:30:00+00:00": 1092.18994140625,
      "2024-07-16T16:30:00+00:00": 1093.56494140625,
      "2024-07-16T17:30:00+00:00": 1090.68994140625,
      "2024-07-16T18:30:00+00:00": 1092.1199951171875,
      "2024-07-16T19:30:00+00:00": 1094.219970703125
    },
    "sentiment": 0.9111994504928589
  },
  {
    "title": "Regeneron: Downgrading My Outlook To 'Hold' Ahead Of Q2 Earnings",
    "published": 1720719711,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 1065.9300537109375,
      "2024-07-11T14:30:00+00:00": 1081.9449462890625,
      "2024-07-11T15:30:00+00:00": 1086.1700439453125,
      "2024-07-11T16:30:00+00:00": 1085.8900146484375,
      "2024-07-11T17:30:00+00:00": 1088.2750244140625,
      "2024-07-11T18:30:00+00:00": 1086.1300048828125,
      "2024-07-11T19:30:00+00:00": 1078.0150146484375
    },
    "sentiment": 0.9451041221618652
  },
  {
    "title": "IN BRIEF: Regeneron says second quarter results to include R&D charge",
    "published": 1720487460,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 1055.8299560546875,
      "2024-07-09T14:30:00+00:00": 1049.300048828125,
      "2024-07-09T15:30:00+00:00": 1055.5450439453125,
      "2024-07-09T16:30:00+00:00": 1057.9150390625,
      "2024-07-09T17:30:00+00:00": 1056.1700439453125,
      "2024-07-09T18:30:00+00:00": 1053.239990234375,
      "2024-07-09T19:30:00+00:00": 1055.3499755859375
    },
    "sentiment": 0.9133156538009644
  },
  {
    "title": "PTAB Invalidates Regeneron Claims On Method Of Treatment",
    "published": 1720433469,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 1039.510009765625,
      "2024-07-08T14:30:00+00:00": 1046.4000244140625,
      "2024-07-08T15:30:00+00:00": 1044.9200439453125,
      "2024-07-08T16:30:00+00:00": 1047.3599853515625,
      "2024-07-08T17:30:00+00:00": 1049.875,
      "2024-07-08T18:30:00+00:00": 1052.81005859375,
      "2024-07-08T19:30:00+00:00": 1051.5550537109375
    },
    "sentiment": 0.5469311475753784
  },
  {
    "title": "Regeneron Expects Earnings Hit After $24 Million R&D Charge",
    "published": 1720425680,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 1039.510009765625,
      "2024-07-08T14:30:00+00:00": 1046.4000244140625,
      "2024-07-08T15:30:00+00:00": 1044.9200439453125,
      "2024-07-08T16:30:00+00:00": 1047.3599853515625,
      "2024-07-08T17:30:00+00:00": 1049.875,
      "2024-07-08T18:30:00+00:00": 1052.81005859375,
      "2024-07-08T19:30:00+00:00": 1051.5550537109375
    },
    "sentiment": 0.8136464953422546
  },
  {
    "title": "Dupixent \u201caddresses current gap\u201d in COPD biologics landscape",
    "published": 1720182803,
    "day_prices": {
      "2024-07-05T13:30:00+00:00": 1027.469970703125,
      "2024-07-05T14:30:00+00:00": 1035.93505859375,
      "2024-07-05T15:30:00+00:00": 1033.5899658203125,
      "2024-07-05T16:30:00+00:00": 1035.2850341796875,
      "2024-07-05T17:30:00+00:00": 1034.989990234375,
      "2024-07-05T18:30:00+00:00": 1033.449951171875,
      "2024-07-05T19:30:00+00:00": 1033.2550048828125
    },
    "sentiment": 0.5586276650428772
  },
  {
    "title": "REGENERON PHARMACEUTICALS, INC. - DUPIXENT APPROVED IN THE EUROPEAN UNION AS THE FIRST-EVER TARGETED THERAPY FOR PATIENTS WITH COPD",
    "published": 1720087094,
    "day_prices": {},
    "sentiment": 0.8869904279708862
  },
  {
    "title": "Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD",
    "published": 1720008360,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 1042.280029296875,
      "2024-07-03T14:30:00+00:00": 1030.344970703125,
      "2024-07-03T15:30:00+00:00": 1021.4500122070312
    },
    "sentiment": 0.9060483574867249
  },
  {
    "title": "Dupixent\u00ae (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD",
    "published": 1719982800,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 1042.280029296875,
      "2024-07-03T14:30:00+00:00": 1030.344970703125,
      "2024-07-03T15:30:00+00:00": 1021.4500122070312
    },
    "sentiment": 0.8468074798583984
  },
  {
    "title": "IN BRIEF: Regeneron's odronextamab recommended for European approval",
    "published": 1719931860,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 1054.0,
      "2024-07-02T14:30:00+00:00": 1036.0799560546875,
      "2024-07-02T15:30:00+00:00": 1040.890869140625,
      "2024-07-02T16:30:00+00:00": 1037.3599853515625,
      "2024-07-02T17:30:00+00:00": 1031.7550048828125,
      "2024-07-02T18:30:00+00:00": 1040.5899658203125,
      "2024-07-02T19:30:00+00:00": 1044.875
    },
    "sentiment": 0.5734987854957581
  },
  {
    "title": "Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness",
    "published": 1719921611,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 1054.0,
      "2024-07-02T14:30:00+00:00": 1036.0799560546875,
      "2024-07-02T15:30:00+00:00": 1040.890869140625,
      "2024-07-02T16:30:00+00:00": 1037.3599853515625,
      "2024-07-02T17:30:00+00:00": 1031.7550048828125,
      "2024-07-02T18:30:00+00:00": 1040.5899658203125,
      "2024-07-02T19:30:00+00:00": 1044.875
    },
    "sentiment": 0.9031426310539246
  },
  {
    "title": "REGENERON - ODRONEXTAMAB RECOMMENDED FOR EU APPROVAL BY THE CHMP TO TREAT RELAPSED, REFRACTORY FOLLICULAR LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA",
    "published": 1719833660,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 1045.0,
      "2024-07-01T14:30:00+00:00": 1064.43994140625,
      "2024-07-01T15:30:00+00:00": 1058.1700439453125,
      "2024-07-01T16:30:00+00:00": 1050.52001953125,
      "2024-07-01T17:30:00+00:00": 1054.3699951171875,
      "2024-07-01T18:30:00+00:00": 1049.5400390625,
      "2024-07-01T19:30:00+00:00": 1053.5849609375
    },
    "sentiment": 0.909153163433075
  },
  {
    "title": "Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More",
    "published": 1724854260,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 1196.06005859375,
      "2024-08-28T14:30:00+00:00": 1203.4000244140625,
      "2024-08-28T15:30:00+00:00": 1202.2249755859375,
      "2024-08-28T16:30:00+00:00": 1205.77001953125,
      "2024-08-28T17:30:00+00:00": 1204.9000244140625,
      "2024-08-28T18:30:00+00:00": 1196.300048828125,
      "2024-08-28T19:30:00+00:00": 1199.8800048828125
    },
    "sentiment": 0.606563925743103
  },
  {
    "title": "Regeneron Pharmaceuticals - Ordspono Approved in the European Union for the Treatment of Relapsed, Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma",
    "published": 1724753489,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 1199.3399658203125,
      "2024-08-27T14:30:00+00:00": 1207.72998046875,
      "2024-08-27T15:30:00+00:00": 1208.72998046875,
      "2024-08-27T16:30:00+00:00": 1199.3399658203125,
      "2024-08-27T17:30:00+00:00": 1201.6099853515625,
      "2024-08-27T18:30:00+00:00": 1203.0,
      "2024-08-27T19:30:00+00:00": 1201.0899658203125
    },
    "sentiment": 0.7971722483634949
  },
  {
    "title": "HRMY or REGN: Which Is the Better Value Stock Right Now?",
    "published": 1724686814,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 1199.1199951171875,
      "2024-08-26T14:30:00+00:00": 1200.655029296875,
      "2024-08-26T15:30:00+00:00": 1197.7750244140625,
      "2024-08-26T16:30:00+00:00": 1200.7850341796875,
      "2024-08-26T17:30:00+00:00": 1206.8094482421875,
      "2024-08-26T18:30:00+00:00": 1200.523193359375,
      "2024-08-26T19:30:00+00:00": 1200.0
    },
    "sentiment": 0.9166535139083862
  },
  {
    "title": "Regeneron gains European approval for bispecific lymphoma drug",
    "published": 1724673540,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 1199.1199951171875,
      "2024-08-26T14:30:00+00:00": 1200.655029296875,
      "2024-08-26T15:30:00+00:00": 1197.7750244140625,
      "2024-08-26T16:30:00+00:00": 1200.7850341796875,
      "2024-08-26T17:30:00+00:00": 1206.8094482421875,
      "2024-08-26T18:30:00+00:00": 1200.523193359375,
      "2024-08-26T19:30:00+00:00": 1200.0
    },
    "sentiment": 0.9509665369987488
  },
  {
    "title": "Ordspono\u2122 (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma",
    "published": 1724670000,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 1199.1199951171875,
      "2024-08-26T14:30:00+00:00": 1200.655029296875,
      "2024-08-26T15:30:00+00:00": 1197.7750244140625,
      "2024-08-26T16:30:00+00:00": 1200.7850341796875,
      "2024-08-26T17:30:00+00:00": 1206.8094482421875,
      "2024-08-26T18:30:00+00:00": 1200.523193359375,
      "2024-08-26T19:30:00+00:00": 1200.0
    },
    "sentiment": 0.7850421667098999
  },
  {
    "title": "Regeneron\u2019s cancer therapy gets EU approval",
    "published": 1724653800,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 1199.1199951171875,
      "2024-08-26T14:30:00+00:00": 1200.655029296875,
      "2024-08-26T15:30:00+00:00": 1197.7750244140625,
      "2024-08-26T16:30:00+00:00": 1200.7850341796875,
      "2024-08-26T17:30:00+00:00": 1206.8094482421875,
      "2024-08-26T18:30:00+00:00": 1200.523193359375,
      "2024-08-26T19:30:00+00:00": 1200.0
    },
    "sentiment": 0.8831169009208679
  },
  {
    "title": "REGENERON PHARMACEUTICALS - LATEST DUPIXENT AND ITEPEKIMAB DATA AT ERS HIGHLIGHT SCIENTIFIC INNOVATION AND LEADERSHIP IN RESPIRATORY DISEASES",
    "published": 1724651855,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 1199.1199951171875,
      "2024-08-26T14:30:00+00:00": 1200.655029296875,
      "2024-08-26T15:30:00+00:00": 1197.7750244140625,
      "2024-08-26T16:30:00+00:00": 1200.7850341796875,
      "2024-08-26T17:30:00+00:00": 1206.8094482421875,
      "2024-08-26T18:30:00+00:00": 1200.523193359375,
      "2024-08-26T19:30:00+00:00": 1200.0
    },
    "sentiment": 0.7806187272071838
  },
  {
    "title": "Regeneron announces latest Dupixent, itepekimab data at ERS",
    "published": 1724645520,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 1199.1199951171875,
      "2024-08-26T14:30:00+00:00": 1200.655029296875,
      "2024-08-26T15:30:00+00:00": 1197.7750244140625,
      "2024-08-26T16:30:00+00:00": 1200.7850341796875,
      "2024-08-26T17:30:00+00:00": 1206.8094482421875,
      "2024-08-26T18:30:00+00:00": 1200.523193359375,
      "2024-08-26T19:30:00+00:00": 1200.0
    },
    "sentiment": 0.9331631660461426
  },
  {
    "title": "Regeneron Gets European OK of Lymphoma Drug Ordspono",
    "published": 1724617080,
    "day_prices": {},
    "sentiment": 0.6516437530517578
  },
  {
    "title": "Alnylam (ALNY) Amvuttra & Givlaari Fuel Revenues Amid Competition",
    "published": 1724422920,
    "day_prices": {
      "2024-08-23T13:30:00+00:00": 1195.719970703125,
      "2024-08-23T14:30:00+00:00": 1200.0999755859375,
      "2024-08-23T15:30:00+00:00": 1196.7850341796875,
      "2024-08-23T16:30:00+00:00": 1198.489990234375,
      "2024-08-23T17:30:00+00:00": 1197.8050537109375,
      "2024-08-23T18:30:00+00:00": 1197.56494140625,
      "2024-08-23T19:30:00+00:00": 1202.2379150390625
    },
    "sentiment": 0.5667487978935242
  },
  {
    "title": "Regeneron confirms FDA won\u2019t approve myeloma drug over manufacturing issues",
    "published": 1724240700,
    "day_prices": {
      "2024-08-21T13:30:00+00:00": 1194.7099609375,
      "2024-08-21T14:30:00+00:00": 1193.2049560546875,
      "2024-08-21T15:30:00+00:00": 1195.280029296875,
      "2024-08-21T16:30:00+00:00": 1189.6400146484375,
      "2024-08-21T17:30:00+00:00": 1189.68994140625,
      "2024-08-21T18:30:00+00:00": 1192.3199462890625,
      "2024-08-21T19:30:00+00:00": 1188.949951171875
    },
    "sentiment": 0.5603827238082886
  },
  {
    "title": "Regeneron (REGN) Gets CRL From FDA for Multiple Myeloma Drug",
    "published": 1724239140,
    "day_prices": {
      "2024-08-21T13:30:00+00:00": 1194.7099609375,
      "2024-08-21T14:30:00+00:00": 1193.2049560546875,
      "2024-08-21T15:30:00+00:00": 1195.280029296875,
      "2024-08-21T16:30:00+00:00": 1189.6400146484375,
      "2024-08-21T17:30:00+00:00": 1189.68994140625,
      "2024-08-21T18:30:00+00:00": 1192.3199462890625,
      "2024-08-21T19:30:00+00:00": 1188.949951171875
    },
    "sentiment": 0.5947869420051575
  },
  {
    "title": "Regeneron receives anticipated FDA rejection for blood cancer therapy",
    "published": 1724216160,
    "day_prices": {
      "2024-08-21T13:30:00+00:00": 1194.7099609375,
      "2024-08-21T14:30:00+00:00": 1193.2049560546875,
      "2024-08-21T15:30:00+00:00": 1195.280029296875,
      "2024-08-21T16:30:00+00:00": 1189.6400146484375,
      "2024-08-21T17:30:00+00:00": 1189.68994140625,
      "2024-08-21T18:30:00+00:00": 1192.3199462890625,
      "2024-08-21T19:30:00+00:00": 1188.949951171875
    },
    "sentiment": 0.7405623197555542
  },
  {
    "title": "BioNTech: Clinical Hold Removal Pushes ADC Development Program Forward",
    "published": 1724174778,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 1196.8800048828125,
      "2024-08-20T14:30:00+00:00": 1193.884033203125,
      "2024-08-20T15:30:00+00:00": 1189.47998046875,
      "2024-08-20T16:30:00+00:00": 1190.9100341796875,
      "2024-08-20T17:30:00+00:00": 1186.5999755859375,
      "2024-08-20T18:30:00+00:00": 1189.199951171875,
      "2024-08-20T19:30:00+00:00": 1195.6700439453125
    },
    "sentiment": 0.8345343470573425
  },
  {
    "title": "Incyte: Monjuvi Advancement Continues With Positive FL Treatment Data",
    "published": 1724079858,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 1180.02001953125,
      "2024-08-19T14:30:00+00:00": 1187.56494140625,
      "2024-08-19T15:30:00+00:00": 1191.469970703125,
      "2024-08-19T16:30:00+00:00": 1190.5350341796875,
      "2024-08-19T17:30:00+00:00": 1193.199951171875,
      "2024-08-19T18:30:00+00:00": 1193.5899658203125,
      "2024-08-19T19:30:00+00:00": 1192.8199462890625
    },
    "sentiment": 0.9474923014640808
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), United Therapeutics (UTHR) and Regeneron (REGN)",
    "published": 1724049060,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 1180.02001953125,
      "2024-08-19T14:30:00+00:00": 1187.56494140625,
      "2024-08-19T15:30:00+00:00": 1191.469970703125,
      "2024-08-19T16:30:00+00:00": 1190.5350341796875,
      "2024-08-19T17:30:00+00:00": 1193.199951171875,
      "2024-08-19T18:30:00+00:00": 1193.5899658203125,
      "2024-08-19T19:30:00+00:00": 1192.8199462890625
    },
    "sentiment": 0.9187561273574829
  },
  {
    "title": "Regeneron Pharmaceuticals' (NASDAQ:REGN) five-year earnings growth trails the incredible shareholder returns",
    "published": 1723896097,
    "day_prices": {},
    "sentiment": 0.9226996898651123
  },
  {
    "title": "Merck: Buy This Bargain Before It's Gone",
    "published": 1723485246,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 1124.6099853515625,
      "2024-08-12T14:30:00+00:00": 1123.4100341796875,
      "2024-08-12T15:30:00+00:00": 1122.6400146484375,
      "2024-08-12T16:30:00+00:00": 1123.10986328125,
      "2024-08-12T17:30:00+00:00": 1121.8199462890625,
      "2024-08-12T18:30:00+00:00": 1116.9599609375,
      "2024-08-12T19:30:00+00:00": 1119.2650146484375
    },
    "sentiment": 0.9159238934516907
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR), Waters (WAT) and Regeneron (REGN)",
    "published": 1723436040,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 1124.6099853515625,
      "2024-08-12T14:30:00+00:00": 1123.4100341796875,
      "2024-08-12T15:30:00+00:00": 1122.6400146484375,
      "2024-08-12T16:30:00+00:00": 1123.10986328125,
      "2024-08-12T17:30:00+00:00": 1121.8199462890625,
      "2024-08-12T18:30:00+00:00": 1116.9599609375,
      "2024-08-12T19:30:00+00:00": 1119.2650146484375
    },
    "sentiment": 0.9181710481643677
  },
  {
    "title": "HRMY vs. REGN: Which Stock Is the Better Value Option?",
    "published": 1723218012,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 1113.0,
      "2024-08-09T14:30:00+00:00": 1118.2099609375,
      "2024-08-09T15:30:00+00:00": 1121.9849853515625,
      "2024-08-09T16:30:00+00:00": 1118.949951171875,
      "2024-08-09T17:30:00+00:00": 1128.6300048828125,
      "2024-08-09T18:30:00+00:00": 1121.02001953125,
      "2024-08-09T19:30:00+00:00": 1128.0899658203125
    },
    "sentiment": 0.9193906784057617
  },
  {
    "title": "Video: S&P 500 Analyst Moves: REGN",
    "published": 1723200480,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 1113.0,
      "2024-08-09T14:30:00+00:00": 1118.2099609375,
      "2024-08-09T15:30:00+00:00": 1121.9849853515625,
      "2024-08-09T16:30:00+00:00": 1118.949951171875,
      "2024-08-09T17:30:00+00:00": 1128.6300048828125,
      "2024-08-09T18:30:00+00:00": 1121.02001953125,
      "2024-08-09T19:30:00+00:00": 1128.0899658203125
    },
    "sentiment": 0.916301965713501
  },
  {
    "title": "3 Biotech Stocks With Promising Drug Pipelines: August 2024",
    "published": 1723113600,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 1074.6199951171875,
      "2024-08-08T14:30:00+00:00": 1091.0,
      "2024-08-08T15:30:00+00:00": 1099.9200439453125,
      "2024-08-08T16:30:00+00:00": 1102.010009765625,
      "2024-08-08T17:30:00+00:00": 1104.280029296875,
      "2024-08-08T18:30:00+00:00": 1110.0,
      "2024-08-08T19:30:00+00:00": 1106.56494140625
    },
    "sentiment": 0.567245602607727
  },
  {
    "title": "Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast",
    "published": 1723061100,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 1074.3800048828125,
      "2024-08-07T14:30:00+00:00": 1069.43994140625,
      "2024-08-07T15:30:00+00:00": 1071.8399658203125,
      "2024-08-07T16:30:00+00:00": 1074.800048828125,
      "2024-08-07T17:30:00+00:00": 1069.489990234375,
      "2024-08-07T18:30:00+00:00": 1065.125,
      "2024-08-07T19:30:00+00:00": 1065.3800048828125
    },
    "sentiment": 0.9510202407836914
  },
  {
    "title": "Nvidia, Meta, Netflix Profit Outlooks Sunny Despite Harsh Selling",
    "published": 1722962710,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 1064.22998046875,
      "2024-08-06T14:30:00+00:00": 1077.52001953125,
      "2024-08-06T15:30:00+00:00": 1085.68994140625,
      "2024-08-06T16:30:00+00:00": 1082.85498046875,
      "2024-08-06T17:30:00+00:00": 1081.3349609375,
      "2024-08-06T18:30:00+00:00": 1080.9998779296875,
      "2024-08-06T19:30:00+00:00": 1074.4200439453125
    },
    "sentiment": 0.9302801489830017
  },
  {
    "title": "Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)",
    "published": 1722898894,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 1084.5,
      "2024-08-05T14:30:00+00:00": 1063.0150146484375,
      "2024-08-05T15:30:00+00:00": 1074.06005859375,
      "2024-08-05T16:30:00+00:00": 1080.4549560546875,
      "2024-08-05T17:30:00+00:00": 1073.7900390625,
      "2024-08-05T18:30:00+00:00": 1074.22998046875,
      "2024-08-05T19:30:00+00:00": 1073.83984375
    },
    "sentiment": 0.8861153721809387
  },
  {
    "title": "Regeneron\u2019s Promising Pipeline and Strong Financial Outlook Merit a Buy Rating with Increased Price Target",
    "published": 1722820740,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 1084.5,
      "2024-08-05T14:30:00+00:00": 1063.0150146484375,
      "2024-08-05T15:30:00+00:00": 1074.06005859375,
      "2024-08-05T16:30:00+00:00": 1080.4549560546875,
      "2024-08-05T17:30:00+00:00": 1073.7900390625,
      "2024-08-05T18:30:00+00:00": 1074.22998046875,
      "2024-08-05T19:30:00+00:00": 1073.83984375
    },
    "sentiment": 0.9533857703208923
  },
  {
    "title": "Is Regeneron Pharmaceuticals Due for a Stock Split?",
    "published": 1722683700,
    "day_prices": {},
    "sentiment": 0.6448601484298706
  },
  {
    "title": "Analyst Ratings For Regeneron Pharmaceuticals",
    "published": 1722589560,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 1105.27001953125,
      "2024-08-02T14:30:00+00:00": 1075.989990234375,
      "2024-08-02T15:30:00+00:00": 1073.8399658203125,
      "2024-08-02T16:30:00+00:00": 1091.0350341796875,
      "2024-08-02T17:30:00+00:00": 1089.824951171875,
      "2024-08-02T18:30:00+00:00": 1087.85498046875,
      "2024-08-02T19:30:00+00:00": 1083.9599609375
    },
    "sentiment": 0.9010616540908813
  },
  {
    "title": "Q2 2024 Regeneron Pharmaceuticals Inc Earnings Call",
    "published": 1722585545,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 1105.27001953125,
      "2024-08-02T14:30:00+00:00": 1075.989990234375,
      "2024-08-02T15:30:00+00:00": 1073.8399658203125,
      "2024-08-02T16:30:00+00:00": 1091.0350341796875,
      "2024-08-02T17:30:00+00:00": 1089.824951171875,
      "2024-08-02T18:30:00+00:00": 1087.85498046875,
      "2024-08-02T19:30:00+00:00": 1083.9599609375
    },
    "sentiment": 0.693132758140564
  },
  {
    "title": "Regeneron's Robust Pipeline And Financial Health Signal Continued Growth",
    "published": 1722584349,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 1105.27001953125,
      "2024-08-02T14:30:00+00:00": 1075.989990234375,
      "2024-08-02T15:30:00+00:00": 1073.8399658203125,
      "2024-08-02T16:30:00+00:00": 1091.0350341796875,
      "2024-08-02T17:30:00+00:00": 1089.824951171875,
      "2024-08-02T18:30:00+00:00": 1087.85498046875,
      "2024-08-02T19:30:00+00:00": 1083.9599609375
    },
    "sentiment": 0.953380286693573
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Regeneron (REGN) and Vir Biotechnology (VIR)",
    "published": 1722579120,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 1105.27001953125,
      "2024-08-02T14:30:00+00:00": 1075.989990234375,
      "2024-08-02T15:30:00+00:00": 1073.8399658203125,
      "2024-08-02T16:30:00+00:00": 1091.0350341796875,
      "2024-08-02T17:30:00+00:00": 1089.824951171875,
      "2024-08-02T18:30:00+00:00": 1087.85498046875,
      "2024-08-02T19:30:00+00:00": 1083.9599609375
    },
    "sentiment": 0.905228853225708
  },
  {
    "title": "Regeneron price target raised by $20 at Barclays, here's why",
    "published": 1722577380,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 1105.27001953125,
      "2024-08-02T14:30:00+00:00": 1075.989990234375,
      "2024-08-02T15:30:00+00:00": 1073.8399658203125,
      "2024-08-02T16:30:00+00:00": 1091.0350341796875,
      "2024-08-02T17:30:00+00:00": 1089.824951171875,
      "2024-08-02T18:30:00+00:00": 1087.85498046875,
      "2024-08-02T19:30:00+00:00": 1083.9599609375
    },
    "sentiment": 0.684403657913208
  },
  {
    "title": "Regeneron: adjusted EPS up 13% in Q2",
    "published": 1722573316,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 1105.27001953125,
      "2024-08-02T14:30:00+00:00": 1075.989990234375,
      "2024-08-02T15:30:00+00:00": 1073.8399658203125,
      "2024-08-02T16:30:00+00:00": 1091.0350341796875,
      "2024-08-02T17:30:00+00:00": 1089.824951171875,
      "2024-08-02T18:30:00+00:00": 1087.85498046875,
      "2024-08-02T19:30:00+00:00": 1083.9599609375
    },
    "sentiment": 0.9550976157188416
  },
  {
    "title": "Regeneron Pharmaceuticals Inc (REGN) Q2 2024 Earnings Call Transcript Highlights: Strong ...",
    "published": 1722560760,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 1105.27001953125,
      "2024-08-02T14:30:00+00:00": 1075.989990234375,
      "2024-08-02T15:30:00+00:00": 1073.8399658203125,
      "2024-08-02T16:30:00+00:00": 1091.0350341796875,
      "2024-08-02T17:30:00+00:00": 1089.824951171875,
      "2024-08-02T18:30:00+00:00": 1087.85498046875,
      "2024-08-02T19:30:00+00:00": 1083.9599609375
    },
    "sentiment": 0.9509866833686829
  },
  {
    "title": "Defensive Sectors Breakout: 3 Stocks to Buy Now for Protection",
    "published": 1722532740,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.7654595375061035
  },
  {
    "title": "Compared to Estimates, Regeneron (REGN) Q2 Earnings: A Look at Key Metrics",
    "published": 1722519033,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.877354621887207
  },
  {
    "title": "Regeneron beats quarterly results on strong demand for eczema, eye treatments",
    "published": 1722516143,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.9418152570724487
  },
  {
    "title": "Regeneron: Q2 Earnings Snapshot",
    "published": 1722508689,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.5682749152183533
  },
  {
    "title": "Regeneron quarterly profit jumps 48% amid rising research spend",
    "published": 1722503400,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.9258803129196167
  },
  {
    "title": "Buy Rating Affirmed for Regeneron on Strong Financials and Positive Sales Outlook",
    "published": 1722499740,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.9520621299743652
  },
  {
    "title": "Regeneron beats in Q2 as Eylea tops expectations",
    "published": 1722496260,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.9333457350730896
  },
  {
    "title": "Regeneron Pharmaceuticals (REGN) Q2 2024 Earnings: EPS Soars to $12.41, Revenue Hits $3.55 Billion",
    "published": 1722493920,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.9322731494903564
  },
  {
    "title": "Regeneron reports Q2 adjusted EPS $11.56, consensus $10.61",
    "published": 1722490320,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.7448027729988098
  },
  {
    "title": "Regeneron\u2019s Strong Market Performance and Financial Growth Bolster Buy Rating",
    "published": 1722475560,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 1060.8599853515625,
      "2024-08-01T14:30:00+00:00": 1075.5450439453125,
      "2024-08-01T15:30:00+00:00": 1098.2650146484375,
      "2024-08-01T16:30:00+00:00": 1092.344970703125,
      "2024-08-01T17:30:00+00:00": 1087.93994140625,
      "2024-08-01T18:30:00+00:00": 1092.2900390625,
      "2024-08-01T19:30:00+00:00": 1091.47998046875
    },
    "sentiment": 0.9577975273132324
  }
]